Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WHO-SOLIDARITY-GERMANY: Remdesivir for COVID-19
NCT04575064Phase 3Withdrawn
- Start
- Jun 2020
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of remdesivir in coronavirus disease 2019 (COVID-19). Planned start Jun 2020; status: withdrawn.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04575064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575064.